{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"short-stature-due-to-growth-hormone-qualitative-anomaly","columns":[{"gene":"","key":"population-2d7120030047479c98e3","label":"Pituitary dwarfism IV","mondoId":"MONDO:0009879","onsetQualifier":null,"originColumnKey":"MONDO:0009879/OMIM:262650","originalViews":[{"key":"MONDO:0009879/OMIM:262650","label":"Pituitary dwarfism IV","scopeLabel":"OMIM:262650","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["6b34d01017493437a38c6d22dcd305199e03de35cdd875b74966952b66ad2fbe","9b131d6714497d6f71ab80a6a8a2b956dd7ce29054cdca24d59526b23eee0451","a4f49c947929401a577a1618c2ab3cfac44214c7ebe796f7c2fbd8e587fb4e39","b6be3a3b4dec7ccbeabf2a2e0ed527ece4c42f8e6926fbf26d525224d6497b71"],"recordQualifiers":{},"scopeLabel":"OMIM:262650","sourceIds":["OMIM:262650"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-2d7120030047479c98e3"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001939","HP:0002750","HP:0001510","HP:0000839"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":4,"sourceGroups":{"omim":4}},"features":[{"hpoId":"HP:0001939","label":"Abnormality of metabolism/homeostasis","primary":true},{"hpoId":"HP:0002750","label":"Delayed skeletal maturation","primary":true},{"hpoId":"HP:0001510","label":"Growth delay","primary":true},{"hpoId":"HP:0000839","label":"Pituitary dwarfism","primary":true}],"ledeHtml":"Short stature due to growth hormone qualitative anomaly is characterised by growth retardation and short stature (despite the presence of normal or slightly elevated levels of immunoreactive growth hormone, GH), low concentrations of insulin-like growth factor-I (IGF-I) and a significant increase in growth rate following recombinant GH therapy. Prevalence is unknown but only a few cases have been reported in the literature. The syndrome is caused by various mutations in the GH1 gene (17q22-q24) that result in structural GH anomalies and a biologically inactive molecule. Transmission is autosomal recessive.","mondoId":"MONDO:0009879","node":{"canonicalSlug":"short-stature-due-to-growth-hormone-qualitative-anomaly","comparisons":[{"documentSha256":"11b3de5053b7d7d7e0ac01a8857da00c3c1ade904a085028136053ae8de47e94","key":"legacy-isolated-growth-hormone-deficiency","kind":"legacy","label":"isolated congenital growth hormone deficiency","memberIds":["MONDO:0000050","MONDO:0008250","MONDO:0009876","MONDO:0009879","MONDO:0010615","MONDO:0013006","MONDO:0032567","MONDO:0032569"],"mondoId":"MONDO:0000050","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/isolated-growth-hormone-deficiency.11b3de5053b7d7d7e0ac01a8857da00c3c1ade904a085028136053ae8de47e94.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Short stature due to growth hormone qualitative anomaly","originalSourceId":"ORPHA:629","paragraphs":["Short stature due to growth hormone qualitative anomaly is characterised by growth retardation and short stature (despite the presence of normal or slightly elevated levels of immunoreactive growth hormone, GH), low concentrations of insulin-like growth factor-I (IGF-I) and a significant increase in growth rate following recombinant GH therapy. Prevalence is unknown but only a few cases have been reported in the literature. The syndrome is caused by various mutations in the GH1 gene (17q22-q24) that result in structural GH anomalies and a biologically inactive molecule. Transmission is autosomal recessive."],"rawAttribution":"MONDO:0009879","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:38:16Z","upstream":"MONDO:0009879","url":"https://rarediseases.info.nih.gov/diseases/408"},"ownColumnKeys":["population-2d7120030047479c98e3"],"publication":"published","relationships":[{"kind":"parent","label":"isolated congenital growth hormone deficiency","mondoId":"MONDO:0000050","slug":"isolated-growth-hormone-deficiency"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published"},"records":[{"frequencyKind":"reported","key":"6b34d01017493437a38c6d22dcd305199e03de35cdd875b74966952b66ad2fbe","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:262650","disease_name":"Pituitary dwarfism IV","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002750","is_excluded":false,"label":"Delayed skeletal maturation","onset_id":null,"reference":"OMIM:262650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"9b131d6714497d6f71ab80a6a8a2b956dd7ce29054cdca24d59526b23eee0451","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:262650","disease_name":"Pituitary dwarfism IV","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000839","is_excluded":false,"label":"Pituitary dwarfism","onset_id":null,"reference":"OMIM:262650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a4f49c947929401a577a1618c2ab3cfac44214c7ebe796f7c2fbd8e587fb4e39","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:262650","disease_name":"Pituitary dwarfism IV","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001939","is_excluded":false,"label":"Abnormality of metabolism/homeostasis","onset_id":null,"reference":"OMIM:262650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"b6be3a3b4dec7ccbeabf2a2e0ed527ece4c42f8e6926fbf26d525224d6497b71","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:262650","disease_name":"Pituitary dwarfism IV","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"OMIM:262650","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/408\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009879\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0009879</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Short stature due to growth hormone qualitative anomaly is characterised by growth retardation and short stature (despite the presence of normal or slightly elevated levels of immunoreactive growth hormone, GH), low concentrations of insulin-like growth factor-I (IGF-I) and a significant increase in growth rate following recombinant GH therapy. Prevalence is unknown but only a few cases have been reported in the literature. The syndrome is caused by various mutations in the GH1 gene (17q22-q24) that result in structural GH anomalies and a biologically inactive molecule. Transmission is autosomal recessive.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/408\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"short-stature-due-to-growth-hormone-qualitative-anomaly","sourceDocuments":[{"name":"GARD: Short stature due to growth hormone qualitative anomaly","reviewed":null,"source_release":"2026-10-25T03:38:16Z","url":"https://rarediseases.info.nih.gov/diseases/408"},{"name":"MONDO: short stature due to growth hormone qualitative anomaly","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009879"}],"sourceNote":"","synonyms":["Kowarski syndrome"],"takeawayHtml":"","title":"short stature due to growth hormone qualitative anomaly"},"schemaVersion":1}
